DataMEDS AI, Inc. (MEDS) SEC Filings & Earnings Calls

Future compliance is conditional; failure to maintain equity in next periodic report may lead to delisting.

“If the Company fails to evidence compliance upon filing its next periodic report it may be subject to delisting.” · word for word

Nasdaq delisting risk due to negative stockholders' equity; company may be delisted if not cured.

“stockholders' equity of $(12,447,801)...no longer satisfied the $2,500,000 minimum stockholders' equity requirement” · word for word

Equity dilution from share issuance for license and vendor conversions; potential further dilution if stock price falls.

“Company agreed to issue REBOOT 666,667 shares...if market value less than $2,000,000, must issue additional shares”

Litigation risk resolved via settlement, but ongoing relationship with settling parties may involve future disputes.

“Settlement agreement covers all released claims, but counterparties include former sellers and affiliates.”

Litigation resolved, removing legal uncertainty.

“Settlement agreement reached; litigation dismissed with prejudice.”

Loss of Helomics revenue stream; transition risk as company focuses on AI infrastructure.

“Helomics was the final operating business from Axe Compute's former identity as Predictive Oncology.”

Widening net loss and reliance on new funding and debt restructuring indicate financial distress.

“Net operating loss increased to $18.363M from $6.672M; $14.5M debt restructured; reverse split to address delisting risk.”

Pending transactions and app launch may not materialize as expected, creating execution risk.

“Pending transaction with multiple entities; app launch expected in September 2026.”

Going concern risk

“These factors raise substantial doubt about the Company’s ability to continue as a going concern.” · word for word

Liquidity constraint

“The decrease in both periods was primarily driven by a significant decline in distribution revenues within Wellgistics, LLC, reflecting the impact of liquidity constraints that limited the Company’s ability to procure and fulfill product orders.” · word for word

Debt restructuring losses

“During the three and six months ended June 30, 2026, the Company recognized a loss on extinguishment of debt of $8,881,694.” · word for word

Going concern risk

“These factors raise substantial doubt about the Company’s ability to continue as a going concern.” · word for word

Liquidity constraint

“The decrease was primarily driven by a significant decline in distribution revenues within the Wellgistics, LLC, reflecting the impact of liquidity constraints that limited the Company’s ability to procure and fulfill product orders during the period.” · word for word

Significant operating losses despite revenue growth; path to profitability uncertain.

“Net operating loss of $7.742 million in Q1-2026.”

Terminated LOIs indicate potential deal execution risk.

“Terminated previously announced non-binding letters of intent with Neuritek and WellCare.” · word for word

Dilution risk from increased share count (104.6M vs 51.9M prior year).

“104.6 million weighted average shares outstanding compared to 51.916 million in Q1-2025.”

Severe shareholder dilution

“to increase the number of shares of common stock available for issuance thereunder by 56,493,936 shares and (2) to adjust the maximum annual increase from three percent (3%) to ten (10%) of shares outstanding.” · word for word

Anti-takeover risk from blank check preferred stock

“To approve an amendment to the Certificate of Incorporation to authorize 10,000,000 shares of the Company’s blank check preferred stock” · word for word

Insider ownership concentration and litigation with former CEO

“All directors and executive officers as a group 41,100,518 41.66%” · word for word

Nasdaq delisting risk

“On December 10, 2025, the Company received a deficiency letter from the Nasdaq Listing Qualifications Staff notifying the Company that the closing bid price of its common stock had fallen below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market” · word for word

Liquidity and going concern risk

“liquidity constraints that restricted the Company’s ability to procure inventory efficiently, caused delays in product shipments, and prevented the Company from achieving the purchasing scale necessary to improve margins” · word for word

Debt default risk

“On February 27, 2026, the Company received a demand letter from Strategic EP, LLC indicating that the Company was in default under the terms of the promissory note.” · word for word

Inventory obsolescence risk

“the Company wrote off approximately $6.0 million in aged inventory” · word for word

Significant operating loss and reliance on stock-based compensation; no revenue disclosed raises going concern risk.

“net operating loss of $33.878 million in the third quarter of 2025” · word for word

Acquisition termination indicates strategic uncertainty.

“acquisition of Peek Healthcare Technologies, Inc. has been terminated” · word for word

Forward-looking statements about product launches and blockchain strategy are highly uncertain.

“expect this product launch may contribute meaningfully to our future revenue growth if successfully commercialized” · word for word

Liquidity crisis

“The decline in revenues was primarily due to the Company’s cash constraints for the majority of the third quarter, which inhibited the Company’s ability to purchase new inventory and delayed shipments in the distribution business.” · word for word

High debt burden

“Total debt $24,809,234 as of September 30, 2025.”

Going concern risk

“In order to proceed with our business plan, we may need to raise additional funds through the issuance of debt, equity or other commercial arrangements that may not be available to us when needed or on terms that we deem favorable.” · word for word